Nanomix Corporation (OTCMKTS:NNMX) Stock In Focus After Announcing Agreement with Mobility Health

September 6, 2022

Leader in the development of mobile, affordable, point-of-care diagnostics, Nanomix Corporation (OTCMKTS:NNMX) on September 2, 2022, announced an agreement with Mobility Health. The agreement will entail the Mobility Health plan and Nanomix to collaborate in the development of Lab Developed Test. The test can be deployed in a fully mobile lab to assess levels of circulating antibodies to COVID-19. Trading Data On Friday, NNMX stock ended flat at $0.2394 with…


Nanomix Corporation (OTCMKTS:NNMX) Stock In Focus After A New Appointment

September 1, 2022

Nanomix Corporation (OTCMKTS:NNMX) announced on August 31, 2022, about appointing Tadd S. Lazarus, M.D., to the Board of Directors as an independent director. Having begun his career at Roche Diagnostics, he has held simultaneous roles in private practice and as Director of Medical and Scientific Affairs, and then as the North American Medical Director for the molecular diagnostics, POC, diabetes, clinical chemistry, and immunology lines of business. Trading Data On…